Rain Therapeutics (RAIN) Financials

$0.85

$-0.01 (-1.66%)

As on 04-Sep-2026 16:23EDT

Market cap

$10 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.01	--	--	--	--	--
Cost of Revenue	0.41	0.02	0.01	--	--	--
Gross Profit	-0.40	-0.02	-0.01	--	--	--
Operating Expenses	10.55	7.71	4.50	0.41	77.14	0.53
Operating Profit (EBIT)	-10.60	-7.73	-4.50	-0.41	-77.14	-0.53
Other Income	--	--	--	--	--	--
Profit before Tax	-11.76	-9.09	-4.53	-0.44	-75.72	4.39
Provision for Tax	--	--	--	--	0.00	0.00
Profit after Tax (Net Income)	-11.76	-9.09	-4.53	-0.44	-75.72	4.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-12.16	-12.75	-5.29	-0.64	-0.21	130.50
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.00	1.25	0.35	--	5.95	0.32
Current Liabilities	13.57	13.29	6.22	1.15	0.53	16.32
Total Liabilities	15.99	1.79	1.28	0.52	0.32	147.14

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.98	1.48	0.51	0.47	0.22	0.99
Current Assets	0.43	0.32	0.77	0.05	0.10	146.15
Total Assets	2.84	1.79	1.28	0.52	0.32	147.14
Total Debt*	8.98	9.50	3.51	0.61	0.17	0.41
Net Current Assets	--	-12.97	-5.45	-1.11	-0.43	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-1.95	-1.32	-0.24	-63.20	-37.46
Cash Flow from Investing Activities	--	-0.99	-0.05	-0.26	47.19	-118.24
Cash from Financing Activities	--	3.12	1.36	0.44	53.18	121.62
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.49	-1.11	-0.66	-0.06	-14.07	0.99
Cash EPS ($)	-1.51	-1.11	-0.66	-0.06	-14.07	0.99
Adjusted Book Value ($)	-1.18	--	--	--	--	29.58
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.24	-0.19	-0.03	-11.74	-8.49
Free Cash Flow per Share ($)	--	-0.36	-0.20	-0.07	-11.75	-8.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	362.00	502.36	1,267.92	-115.72	9.34
ROE (%)	--	100.82	153.00	102.75	-116.24	9.43
ROA (%)	-178.74	-592.35	-505.38	-104.22	-102.70	4.21
EBIT Margin (%)	-62,993.22	--	--	--	--	--
Net Margin (%)	-112,028.80	--	--	--	--	--
Cash Profit Margin (%)	-4.31	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-23.51	-95.56	-998.51	99.47	-49.40	-146.48
Net Profit Growth (%)	-77.88	-100.53	-937.46	99.42	-1,826.17	122.85
EPS Growth (%)	-58.41	-0.68	-9.37	1.00	-15.15	1.09
Book Value Growth (%)	-52.49	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.26	--	-18.84	-0.57	12.95
Price / Book Value	--	-3.75	--	-12.93	-201.44	0.44
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-6.50	--	-22.17	0.33	-17.31
Close Price ($)	2.07	5.84	--	1.20	8.00	12.88
High Price ($)	8.50	8.50	--	14.48	14.03	23.90
Low Price ($)	1.26	1.43	--	0.82	2.15	11.04
Market Cap ($ Cr)	9.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.75	-0.66	-0.96	-0.80	0.00
Short term debt to equity ratio	-0.73	-0.75	-0.66	-0.96	-0.80	0.00
Current Ratio	0.03	0.02	0.12	0.04	0.19	8.96
Quick Ratio	0.03	--	--	--	--	8.63
Interest Coverage	-15.08	-30.96	-148.90	-15.16	--	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	34,209.58	38,360.07	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.